Ebarle, Hannah Mae .

HRN: 24-08-29  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/13/2023
CEFUROXIME 1.5GM (VIAL)
11/13/2023
11/19/2023
IVT
600mg
Q8
Uti, Bfc
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: